Blue Apron (APRN) reported a planned $78M equity capital raise on September 15th. The stock is up 40% in 2021. The next stock that George Tsilis discusses is Autoliv (ALV), an automotive safety supplier. Barclays recently upgraded the stock to overweight with a $105 price target. Finally, he discusses Protagonist Therapeutics (PTGX), a clinical stage biopharmaceutical company. The stock was a mover today and was upgraded at Northland Capital to outperform with a $40 price target.
11 Oct 2021
Market On Close
22 Apr 2022
Morning Trade Live
04 Apr 2022
Market On Close
14 Apr 2022
Trading 360
19 Apr 2022
Morning Trade Live
21 Apr 2022
Market On Close
03 Jun 2022